Tamoxifen induces ultrastructural alterations in membranes of Bacillus Stearothermophilus

Toxicology in Vitro

Volumn 17, Issue 5-6, 2003, Pages 623-628

  Luxo, C ^a,b   Jurado, A S ^b   Madeira, Vítor M C ^b   Silva, M T ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Bacillus stearothermophilus; Tamoxifen; Ultrastructural membrane alterations

Indexed keywords

TAMOXIFEN;

BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIAL STRAIN; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DRUG ACTIVITY; DRUG EFFECT; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; GEOBACILLUS STEAROTHERMOPHILUS; GEOMETRY; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; MOLECULAR DYNAMICS; NONHUMAN; RIBOSOME;

BACTERIA (MICROORGANISMS); GEOBACILLUS STEAROTHERMOPHILUS;

EID: 0242266959     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(03)00113-9     Document Type: Conference Paper

References (47)

1. Balasubramanian S.V., Straubinger R.M. Taxol lipid interactions. taxol-dependent effects on the physical properties of model membranes Biochemistry. 33:1994;8941-8947.
2. Bloom M., Evans E., Mouritsen O.G. Physical properties of the fluid lipid-bilayer component of cell membranes. a perspective Quarterly Reviews of Biophysics. 24:1991;293-397.
3. Cai J., Lee C.W. Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells. Biochemical Journal. 320:1996;991-995.
4. Canaves J.M., Ferragut J.A., Gonzalez-Ros J.M. Verapamil prevents the effects of daunomycin on the thermotropic phase transition of model lipid bilayers. Biochemical Journal. 279:1991;413-418.
5. Cardoso C.M.P., Custódio J.B.A., Almeida L.M., Moreno A.J.M. Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency. Toxicology and Applied Pharmacology. 176:2001;145-152.
6. Cardoso, C. M. P., Moreno A. J. M., Almeida, L. M. and Custódio, J. B. A. (2002) 4-Hydroxytamoxifen induces slight uncoupling of mitochondrial oxidative phosphorylation system in relation to the deleterious effects of tamoxifen. Toxicology in press.
7. Charlier C., Chariot A., Antoine N., Merville M., Gielen J., Castronovo V. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-345 cells. Biochemical Pharmacology. 49:1995;351-358.
8. Chen Y., Schindler M., Simon S.M. A mechanism for tamoxifen-mediated inhibition of acidification. Journal of Biological Chemistry. 274:1999;18364-18373.
9. Croxtall J.D., Emmas C., White J.O., Choudhary Q., Flower R.J. Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells. Biochemical Pharmacology. 47:1994;197-202.
10. Cruz Silva M.M., Madeira V.M.C., Almeida M.L., Custódio J.B.A. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. Biochimica et Biophysica Acta. 1464:2000;49-61.
11. Custódio J.B.A., Almeida L.M., Madeira V.M.C. A reliable and rapid procedure to estimate drug partitioning in biomembranes. Biochemical and Biophysical Research Communications. 176:1991;1079-1085.
12. Custódio J.B.A., Almeida L.M., Madeira V.M.C. The anti-cancer drug tamoxifen induces changes in the physical properties of model and native membranes. Biochimica et Biophysica Acta. 1150:1993;123-129.
13. Custódio J.B.A., Almeida L.M., Madeira V.M.C. Tamoxifen and hydroxytamoxifen as intramembranous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochemical Pharmacology. 47:1994;1989-1998.
14. Custódio J.B.A., Almeida L.M., Madeira V.M.C. The effect of the anticancer drugs tamoxifen and hydroxytamoxifen on the calcium pump of isolated sarcoplasmic reticulum vesicles. Toxicology in vitro. 10:1996;523-531.
15. 2+ and inorganic phosphate. Toxicoloy and Applied Pharmacology. 152:1998;10-17.
16. Donato M.M., Jurado A.S., Antunes-Madeira M.C., Madeira V.M.C. Bacillus stearothermophilus as a model to evaluate membrane toxicity of a lipophilic environmental pollutant (DDT). Archives Environmental Contamination and Toxicology. 33:1997;109-116.
17. Donato M.M., Jurado A.S., Antunes-Madeira M.C., Madeira V.M.C. Effects of lipophilic environmental pollutant (DDT) on the phospholipid and fatty acid contents of Bacillus stearothermophilus. Archives Environmental Contamination and Toxicology. 33:1997;341-349.
18. Donato M.M., Jurado A.S., Antunes-Madeira M.C., Madeira V.M.C. Comparative study of toxic actions of 2,2-bis-(p-chlorophenyl)-1,1,1- trichloroethane 2,2-bis-(p-chlorophenyl)-1,1-dichloroethylene on the growth and respiratory activity of a microorganism used as model. Applied Environmental Microbiology. 63:1997;4948-4951.
19. Ellerby H.M., Martin S.J., Ellerby L.M., Naiem S.S., Rabizadeh S., Salvesen G.S., Casiano C., Cashman N.R., Green D.R., Bredsen D.E. Establishment of a cell-free system of neuronal apoptosis. comparison of premitochondrial mitochondrial and posmitochondrial phases Journal of Neuroscience. 17:1997;6165-6178.
20. Gelmann E.P. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers. new tricks for na old dog? Journal of National Cancer Institute. 88:1996;224-226.
21. Kon O.L. Estrogens, antiestrogens and cell proliferation. Bioessays. 10:1989;210-214.
22. Lam H.-Y. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochemical and Biophysical Research Communications. 118:1984;27-32.
23. Lazier C.B. Interactions of tamoxifen in the chicken. Journal of Steroid Biochemistry and Molecular Biology. 27:1987;882-887.
24. 2+-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Research. 50:1990;2753-2758.
25. Luxo C., Jurado A.S., Custódio J.B.A., Madeira V.M. Use of Bacillus stearothermophilus as a model to study tamoxifen-membrane interactions. Toxicology in vitro. 10:1996;463-471.
26. Luxo C., Jurado A.S., Madeira V.M. Lipid composition changes induced by tamoxifen in a bacterial model system. Biochimica et Biophysica Acta. 1369:1998;71-84.
27. Neven P., Vernaeve H. Guidelines for monitoring patients taking tamoxifen treatment. Drug Saffety. 22:2000;1-11.
28. O'Brian C.A., Liskamp R.M., Solomon D.H., Weinstein I.B. Triphenyl ethylenes. a new class of protein kinase inhibitors Journal of the National Cancer Institute. 76:1986;1243-1246.
29. Radmacher M.D., Simon R. Estimation of tamoxifen's efficiency for preventing the formation and growth of breast tumors. Journal of the National Cancer Institute. 92:2000;48-53.
30. Ratledge C., Wilkinson S.G. Fatty acids, related and derived lipids. Ratledge C., Wilkinson S.G. Microbial Lipids. Vol. I. 1988;2-53 Academic Press, London.
31. Rosa S.M.L.J., Antunes-Madeira M.C., Matos M.J., Jurado A.S., Madeira V.M.C. Amiodarone interactions with membrane lipids and with growth of Bacillus stearothermophilus used as a model. Applied Biochemistry and Biotechnology. 87:2000;165-175.
32. Rosa S.M.L.J., Antunes-Madeira M.C., Matos M.J., Jurado A.S., Madeira V.M.C. Lipid composition and dynamics of cell membranes of Bacillus stearothermophilus adapted to amiodarone. Biochimica et Biophysica Acta. 1487:2000;286-295.
33. Rowlands M.G., Parr I.B., McGague R., Jarman M., Goddard P.M. Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlation with cytotoxicity. Biochemical Pharmacology. 40:1990;283-289.
34. Russell N.J. Functions of lipids: structural roles and membranes functions. Ratledge C., Wilkinson S.G. Microbial Lipids. Vol. II. 1989;279-365 Academic Press, London.
35. Santos-Mota J.M., Silva M.T., Carvalho-Guerra F. Ultrastructural and chemical alterations induced by dicumarol in Streptococcus faecalis. Biochimica et Biophysica Acta. 249:1971;114-121.
36. Shuterland R.L., Murphy L.C., Foo M.S., Green M.D., Whybourn A.M., Krozowski Z.S. High-affinity anti-oestrogen binding site distinct from the oestrogen receptor. Nature. 288:1980;273-275.
37. Sica G., Natoli C., Marchetti P., Piperno S., Iacobeli S. Tamoxifen induced membrane alterations in human breast cancer cells. Journal of Steroid Biochemistry. 20:1984;425-428.
38. Sikkema J., de Bont J.A.M., Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiological Reviews. 59:1995;201-222.
39. Silva M.T. Electron microscopic aspects of membrane alterations during bacterial cell lysis. Experimental Cell Research. 46:1967;245-251.
40. Silva M.T., Macedo P. M A comparative ultrastructural study of the membranes of Mycobacterium leprae and of cultivable Mycobacterium. Biology of the Cell. 47:1983;383-386.
41. Silva M.T., Appelberg R., Silva M.N.T., Macedo P.M. In vivo killing and degradation of Mycobacterium aurum with mouse peritoneal macrophages. Infection and Immunity. 55:1987;2006-2016.
42. Silva M.T., Sousa J.C.F., Balassa G. Ultrastructural effects of chemical agents and moist heat on Bacillus subtilis. Annals of Microbiology. 129B:1978;363-375.
43. Silva M.T., Sousa J.C.F., Macedo M.A.E., Polónia J., Parente A.M. Effects of phenetyl alcohol on Bacillus and Streptococcus. Journal of Bacteriology. 127:1976;1359-1369.
44. Silva M.T., Sousa J.C.F., Polónia J.J., Macedo P.M. Effects of local anesthetics on bacterial cells. Journal of Bacteriology. 137:1979;461-468.
45. Van den Koedijk C.D.M.A., Blankenstein M.A., Thijssen J.H.H. Speculation on the mechanism of action of triphenylethylene antioestrogens. Biochemical Pharmacology. 47:1994;1927-1937.
46. Wiseman H., Laughton M.J., Arnestein H.R.V., Cannon M., Haliwell B. The antioxidant action of tamoxifen and its metabolites. Inhibition of lipoperoxidation FEBS Letters. 236:1990;192-194.
47. Wright S.E., White J.C. Membrane ordering effects of the anticancer agent VM-26. Biochimica et Biophysica Acta. 863:1986;297-304.